Autologous Transplantation for Chronic Myelogenous Leukemia

NCT01003054 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelogenous Leukemia

Interventions

DRUG: Busulfan
DRUG: Cyclophosphamide
DRUG: Imatinib Mesylate
PROCEDURE: Autologous Stem Cell Transplantation

Sponsor

M.D. Anderson Cancer Center